USRDThemes US R&D Champions ETF

Grow my money2y track recordRanked #2,260 of 2,960 in this goal

Seeks to track the performance of an index composed of innovative US companies with strong investment in R&D and profitability.

By Themes ETF Trust · Launched 2023

Annual Cost

0.29%

#1,391 of 5,562 · low cost

Fund Size

$1M

#5,435 of 5,562 · small

Return (1Y)Goal

+19.8%

Track Record

2 years

#3,335 of 5,562 · seasoned

Performance

Total-return NAV · USD

Growth of $10,000

$12,115+21.1%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Cap

Multi cap

Strategy

Index tracking

Factor

Quality

Sector

Information technology

Focus

General Innovation

Index tracked

Solactive US R&D Champions Index

What it actually holds

By weight

Concentration

Top 10 holdings = 23.6% of fund✓ well diversified

Eli Lilly & Co

2.6%

Kenvue Inc

2.5%

Regeneron Pharmaceuticals Inc

2.5%

Keysight Technologies Inc

2.3%

Alphabet Inc

2.3%

Applied Materials Inc

2.3%

Johnson & Johnson

2.3%

Corteva Inc

2.3%

Lam Research Corp

2.3%

GE HealthCare Technologies Inc

2.3%

Asset allocation

Stocks

99.9%

Cash

0.1%

Other

0.0%

By sector

Technology

64.5%

Healthcare

14.3%

Consumer Cyclical

7.3%

Communication

7.0%

Industrials

3.6%

Basic Materials

1.7%

Real Estate

1.6%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

17.8%Moderate

Year-on-year price swings

Max drawdown

-23.8%Moderate

Worst peak-to-trough loss

Sharpe (3Y)

Unavailable

Needs 3+ years of history

Sortino (3Y)

Not yet

Needs 3+ years of history

Where to buy

Listing

Exchange: NASDAQ Global Select Market

Full fund details

Objective: Seeks to track the performance of an index composed of innovative US companies with strong investment in R&D and profitability.
Strategy: Employs a passive management approach to track the Solactive US R&D Champions Index, which includes large- and mid-cap US companies with high R&D intensity. The Fund invests at least 80% of its net assets in securities that comprise the Index, using a replication strategy.
Inception date: December 12, 2023
Fund family: Themes ETF Trust